Koye Pharmaceuticals

What Koye Pharmaceuticals does

Koye Pharmaceuticals Pvt. Ltd. is an India-based branded pharmaceutical company founded in 2013 by Preetish Toraskar and Ravindra Y. Shenoy, both former senior executives at multinational pharma firms. Headquartered in Mumbai, it develops, manufactures, and commercializes prescription medicines, consumer healthcare products, nutraceuticals, ayurvedic formulations, and medical devices across therapeutic areas including Women Healthcare, Respiratory Care, Primary Care, Diabetes/Cardio, Gynaecology, and IVF. Its portfolio is organized into Koye Rx (prescription brands under ORIGYN and EQUILA), Koye Consumer Health (KCH plus Celin, CurcunexG, Swayos, Myfy), and Koye Med Devices (Lubo airway collar, AG Cuffill, SUREON consumer devices).

The company's technology base rests on proprietary formulation platforms such as Augmented Absorption Technology (used in CurcunexG for 90x curcumin absorption, patented in India and the USA), Proyurveda (a probiotic + ayurvedic herb combination), and a U.S. patent-pending soluble fiber supplement (Myfy). It operates KOLLAB, a doctor-facing platform aggregating healthcare service providers including Legato, Remedo, MedVideos, MedShorts, Scientific Resources, and Encyclopedia.

Koye generates revenue through one-time sales of prescription and OTC products via a 1,250+ person field force reaching more than 80,000 doctors monthly across India, supplemented by retail pharmacy distribution for consumer brands and institutional supply of medical devices. Revenue is not publicly disclosed, but the company was recognized with sales of more than 100 Crores achieved in under 36 months (2016 Awacs Award), and has secured institutional capital from InnoVen Capital (2016), Premji Invest (2018), and BlackSoil (2020), with Warburg Pincus reported as targeting the company as of March 2026.

Name

Koye Pharmaceuticals

Legal name

Koye Pharmaceuticals Pvt. Ltd.

Website

https://koye.co

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Koye Pharmaceuticals is an Indian branded pharma company selling prescription drugs, consumer health products, ayurvedic formulations, and medical devices across Women Healthcare, Respiratory, Primary Care, and Diabetes/Cardio segments to 80,000+ doctors and lakhs of households through a 1,250+ strong pan-India field force.

Ownership category

akta.pro rank

Product category

Branded Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Multivitamins & Daily Packs (CRADAGAC)

Keywords

• Branded pharmaceuticals
• Prescription drugs
• Medical devices
• Consumer healthcare
• Nutraceutical supplements

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Prescription Pharmaceutical Products (Koye Rx): Wide array of prescription products across Women Healthcare, Respiratory Care, Primary Care, Diabetes Care, Gynaecology, IVF and Cardio-Diabetic segments sold through healthcare professionals
2. Consumer Healthcare Products: OTC, FMCG and Ayurveda segment products including Celin franchise (legacy brand over 75 years), CurcunexG, Swayos, and Myfy sold to consumers through retail channels
3. Medical Devices: Products including Lubo (non-invasive airway collar), AG Cuffill, and K&H consumer health devices sold to healthcare providers and consumers
4. Nutraceuticals: Vitamin and mineral supplements including Mimuvit, Coecoral, Celin range, and various nutraceutical products for wellness and health support

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Koye Pharmaceuticals manufactures and markets branded pharmaceutical formulations, nutraceuticals, Ayurvedic products, and medical devices for the Indian healthcare market. Its portfolio spans prescription products across women healthcare, respiratory, primary care, diabetes and cardio-vascular segments (Koye Rx), consumer health offerings including vitamin supplements, immunity boosters, fiber supplements and Ayurvedic remedies (KCH, Myfy, Swayos, CurcunexG, Celin), and medical devices such as the Lubo non-invasive airway collar and AG Cuffill airway cuff pressure controller. Revenue is generated through a 1250+ strong field sales force detailing prescription brands to doctors and through retail distribution of consumer healthcare products.

Product overview

Koye Pharmaceuticals is an eight-year-old Indian pharmaceutical company founded in 2013 by Mr. Preetish Toraskar and Mr. Ravindra Y. Shenoy, operating across India with 1250+ employees. The company offers a multi-segment portfolio organized into three main divisions: Koye Rx (prescription products for Women Healthcare, Respiratory Care, Primary Care, and Diabetes Care), Koye Consumer Health (OTC, FMCG, and Ayurveda products), and Koye Med Devices. The Koye Rx portfolio includes specialized product lines such as Pregcert (pregnancy/infertility), Dinogest (endometriosis), Coecoral (calcium supplements), CoeHB (hematinics), Celin (vitamin C/nutraceuticals with a 75+ year legacy), Spiromont/Spirodin/Spiroflut (respiratory), Daglipack/Glimipack/Tenipack/Equisulin (diabetes care), Rosupack (lipid lowering), Benepack/Telmipack (hypertension), and Mimuvit (vitamins). Consumer products include Myfy (fiber supplement), Swayos (Ayurvedic range), CurcunexG (curcumin immunity booster), and Pain Free/Cough Free (OTC remedies), 6XE (sexual health), and SUREON medical devices. Medical devices include Lubo (airway collar) and AG Cuffill (cuff pressure measurement). The company also operates KOLLAB, a collaborative platform for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

• KCH (Koye Consumer Health): Consumer health products division including medical devices (thermometers, blood pressure monitors, weighing scales, nebulizers, vaporizers), pain management products, cough remedies, health supplements, and personal care products.
• ORIGYN
• EQUILA
• Myfy
• Swayos
• CurcunexG
• AG Cuffill
• Lubo

Products and services

• Koye Rx (Prescription Pharmaceutical Portfolio) Wide range of prescription pharmaceutical formulations sold to physicians and hospitals across India through a 1250+ ambassador field sales force, covering therapeutic segments in Women Healthcare (pregnancy management, infertility, endometriosis, hematinics), Respiratory Care (allergic rhinitis, asthma, cough), Primary Care (anti-infectives, pain management), and Diabetes/Cardio-Diabetic Care (oral anti-diabetics, insulin, lipid lowering, anti-hypertensives).
• KCH (Koye Consumer Health) Consumer health division offering OTC, FMCG wellness, and home healthcare products including pain management solutions (Pain Free), cough remedies (Cough Free), home diagnostics (Free Check pregnancy test kits), sexual wellness (6XE), and SUREON-branded medical devices such as digital thermometers, blood pressure monitors, weighing scales, nebulizers and vaporizers for retail consumers across India.
• Myfy (Soluble Fiber Supplement) Soluble fiber supplement made from wheat and guar fibers, free of sugar, additives and preservatives, scientifically formulated to address fiber deficiency and boost fiber intake. The formulation is patent pending in the U.S. and is targeted at Indian consumers and patients recommended by doctors for daily fiber intake.
• Swayos (Ayurvedic Product Range) All-natural Ayurvedic product range that combines probiotics with Ayurvedic herbs under the company's Proyurveda technology, where probiotics are stimulated with Ayurvedic herbs and herbal activity is enhanced due to probiotics. The range includes Aahar (herbal dietary supplements) and Aushadh (Ayurvedic medicines with probiotics), positioned for consumers seeking natural immunity and wellness products.
• CurcunexG (Curcumin Immunity Drops) Curcumin-based immunity booster formulated using the company's proprietary Augmented Absorption Technology, with water soluble particles of Curcuminoids and Non-curcuminoids that deliver 90x better absorption in the human body compared to standard curcumin products. The formulation is patented in India and USA and is sold to consumers seeking immunity support.
• Lubo (Non-Invasive Airway Collar) Non-invasive medical device collar that opens the airway by imitating the jaw thrust manoeuvre while simultaneously protecting the cervical spine, enabling hands-free airway management for clinical use. It is radiolucent, latex-free, and MR and X-Ray compatible, intended for anaesthesia and emergency airway management in hospitals.
• AG Cuffill (Cuff Pressure Measurement Device) Compact, pocket-size syringe-like medical device for measuring cuff pressure and controlling the volume of airway cuffs in clinical and anaesthesia settings, with measurement range 0-99 mmHg/cmH2O and accuracy of plus or minus 2 mmHg/cmH2O, designed for healthcare professionals managing intubated patients.
• Celin (Legacy Vitamin C / Nutraceutical Franchise) Legacy vitamin C and immunity nutraceutical franchise with over 75 years of brand equity, spanning prescription and OTC formats including Celin Injection, Celin Kid Syrup, Celin R Capsules, Celin-R Syrup and Celin Zinc Tablets, recommended by doctors and trusted by consumers for immunity and vitamin C supplementation.

Quantifiable outcome

• Reached lakhs of households in the past year
• +2 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

Feature6 records

Partnerships

One partnership is on record.

• KOLLAB Partners (Legato, S-Dash, Remedo, MedVideos, MedShorts, Scientific Resources, Encyclopedia)coreGTM or Marketing PartnerKOLLAB is a unique collaborative program from KOYE bringing together the best service providers in Healthcare, Technology and Allied Services on ONE platform. Partners include Legato (healthcare services), S-Dash, Remedo, MedVideos, MedShorts, Scientific Resources, and Encyclopedia.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cipla: Cipla is one of India's largest pharma companies with deep respiratory, cardio, and OTC presence globally. Comparable to Koye on respiratory and chronic-disease therapeutic overlap, though operates at vastly larger scale across multiple geographies.
• Intas Pharmaceuticals: Intas is a large privately held Indian pharma with strong specialty focus across neurology, cardiology, and gynecology, plus a biosimilars platform. Comparable to Koye on India-centric specialty Rx and private ownership model, though much larger in scale.
• Glenmark Pharmaceuticals: Glenmark is a major Indian-headquartered specialty pharma with presence in respiratory, dermatology, and oncology. Comparable to Koye on specialty-Rx focus and respiratory therapeutic overlap, but operates at significantly larger scale with global footprint.
• Torrent Pharmaceuticals: Torrent Pharma is a larger Indian specialty pharma with strong chronic-disease (cardio, neuro, gastro) coverage. Comparable to Koye on cardiometabolic and specialty focus, but materially larger and more diversified geographically.

Direct peers

• Alkem Laboratories: Alkem is a leading Indian specialty pharma company with strong presence in anti-infectives, gastro, and chronic care, plus a growing consumer health line. Closely comparable to Koye in therapeutic mix (primary care, specialty Rx) and pan-India field force distribution model.
• Ajanta Pharma: Ajanta Pharma is an Indian specialty pharma focused on cardiology, dermatology, ophthalmology, and pain management with strong domestic and emerging-market presence. Comparable to Koye in its specialty-Rx focus and India-centric branded formulation strategy.
• Mankind Pharma: Mankind Pharma is one of India's largest domestic-focused branded pharma companies with strong OTC, consumer health, and chronic-disease portfolios. Most directly comparable to Koye's mix of prescription specialties, consumer brands, and primary-care reach, though materially larger and now public.
• Eris Lifesciences: Eris is a chronic-disease focused Indian pharma with deep cardiometabolic, gynecology, and IVF specialty coverage. Most directly comparable to Koye on the women-healthcare, cardio-diabetic, and chronic-disease specialty prescription model with a similar field force approach.
• JB Chemicals & Pharmaceuticals: JB Chemicals is an Indian specialty pharma with strong consumer health brands and chronic-disease Rx portfolio. Comparable to Koye in the dual Rx + OTC brand-building strategy and India-centric distribution.
• Macleods Pharmaceuticals: Macleods is a privately held Indian pharma with broad specialty and OTC portfolio across chronic and acute therapies. Closely comparable to Koye as a privately held, founder-led, India-centric pharma with multi-therapy breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/KoyePharmaceuticals
• LinkedInlinkedin.com/company/koye-pharmaceuticals-pvt-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Koye Pharmaceuticals